Study of Zanzalintinib in Children and Adolescents With Relapsed or Refractory Solid Tumors
Study of Zanzalintinib in Children and Adolescents With Relapsed or Refractory Solid Tumors
Not yet recruiting · NCT07773454 · Registry updated 2026-08-19Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Study of Zanzalintinib in Children and Adolescents With Relapsed or Refractory Solid Tumors | Disease Attributes, Neoplasms by Histologic Type, Neoplasms by Site, Neoplasms, Germ Cell and Embryonal, Neoplasms, Nerve Tissue, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Recurrence, brain disorder, cancer, central nervous system cancer, central nervous system disorder, childhood malignant neoplasm, neoplasm, nervous system disorder, neuroendocrine neoplasm, primitive neuroectodermal tumor | Not yet recruiting | Phase 1 | 2026-08-19 | NCT07773454 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Exelixis | 77 |
0 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| No products are listed yet. | |||